Navigation Links
MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
Date:8/3/2009

MOUNTAIN VIEW, Calif., Aug. 3 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the second quarter ended June 30, 2009.

The net loss for the quarter ended June 30, 2009 was $5.0 million, compared to $16.5 million during the same period in 2008. The net loss for the first six months of 2009 was $14.9 million, compared to $30.8 million for the first six months of 2008. As of June 30, 2009, MAP Pharmaceuticals had cash, cash equivalents, short-term investments and accounts receivables of $59.9 million.

"We are very pleased that in the first Phase 3 trial for our LEVADEX(TM) migraine therapy, all four primary endpoints were met with statistical significance," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals. "With these positive results in hand and our recent decision to suspend development of Unit Dose Budesonide (UDB), we are now focusing our efforts on the development of LEVADEX. We believe that LEVADEX has a differentiated profile, with the potential to provide rapid and sustained relief of migraine symptoms, and could offer benefit to many of the approximately 30 million migraine sufferers in the U.S., including many who are not helped by currently available migraine therapies. We look forward to presenting the data from our successful Phase 3 trial of LEVADEX at the 14th Congress of the International Headache Society in September."

Second Quarter and Six Month Financial Results

Revenues for the quarter and six months ended June 30, 2009 were $8.6 million and $16.1 million, respectively, compared to $0 for the same periods in 2008. The collaboration revenue to date in 2009 was due to the amortization of a $40.0 million upfront payment received in February
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Bay Pines VA Healthcare ... across southwest Florida by hiring more doctors and nurses and expanding existing facilities and ... , In early July, Dr. Anthony Jabre was selected to lead and grow the ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. ... was one of the first doctors in the area to perform minimally invasive ... have been impressive: faster recovery, decreased immediate and long-term pain, and an accelerated ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Stewart Shofner of ... during Amblyopia Awareness Month. Only a comprehensive eye examination can diagnose amblyopia. According to ... visual impairment among children, affecting approximately 2 to 3 out of every 100 children. ...
(Date:8/31/2015)... ... ... The dental implant and prosthetic market in the U.S. is projected to ... Press Room ) More than 30 million Americans are missing all their teeth in ... dental implants, the National Association of Dental Laboratories (NADL) created the “What’s In Your ...
Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... -- The LENA Foundation announced today that its ... detectable acoustic patterns in the recorded vocalizations of children ... recordings of 76 typically developing children, 30 language-delayed children, ... distinguish between non-autistic and autistic children with better than ...
... Researchers at Emory University School of Medicine created the ... new onset heart failure in the elderly. Now ... a separate library of patient data from an earlier ... risk model can be used to identify high-risk individuals ...
... 12-bit ADC reduces I/O pin count and ... Calif., March 30 /PRNewswire/ -- ... solutions for intelligent data conversion, today ramps ... converters (ADCs) integrated with the company,s compression ...
... Shows More than Half of Americans Still Avoid the Dental ... dentist plagues more than 80 percent of American adults, and ... to see the dentist, according to a new survey by ... can lead to serious health problems, the AAE is tackling ...
... plans at a rate not seen in more than twenty years, ... medical insurance for small business is being called a top priority ... Business and (NFIB) and America,s Health Insurance Plans (AHIP). , ... ...
... two-thirds lacked this type of service within past year, ... Most American teens don,t receive the appropriate amount of ... can establish good health behaviors and discourage damaging behaviors ... life, a new study finds. , The University of ...
Cached Medicine News:Health News:LENA Foundation Announces the Development of an Automatic Autism Screen 2Health News:Heart failure risk model validated 2Health News:Samplify Rolls Production Quantities of Its SAM1600 Analog/Digital Converters with Real-Time Data Compression 2Health News:Samplify Rolls Production Quantities of Its SAM1600 Analog/Digital Converters with Real-Time Data Compression 3Health News:Getting to the Root of Dental Phobia 2Health News:Getting to the Root of Dental Phobia 3Health News:Getting to the Root of Dental Phobia 4Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 3Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 4Health News:Most Teens Aren't Getting Preventive Health Care 2
(Date:8/31/2015)... Calif. , Aug. 31, 2015   Sanofi ... life sciences team at Google announced today that they ... with type 1 and type 2 diabetes. The collaboration ... expertise in analytics, miniaturized electronics and low power chip ... care by developing new tools that bring together many ...
(Date:8/31/2015)... Aug. 31, 2015  AMRI (NASDAQ: AMRI ... strategic collaboration focused on the development, manufacture and ... ingredients, ("APIs"). The collaboration combines Saneca,s strength in ... in developing and manufacturing controlled substance APIs with ... transfer processes into these facilities. The collaboration will ...
(Date:8/31/2015)...  QT Vascular Ltd., together with its subsidiaries ... its subsidiaries, the "Group"), a global company engaged ... therapeutic solutions for the minimally invasive treatment of ... the below-the-knee ("BTK") cohort of patients in the ... on August 15, 2015 at the 5th Annual ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... Calif., Jan. 18, 2011 Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today that Eric Pauwels has joined Accuray ... 17, 2011. Pauwels is a global industry leader ... top-tier U.S. and European bio-pharmaceutical companies. He has successfully developed ...
... today that TMC , a global, integrated media ... has named the Cardiocom Commander® Telehealth System as a ... Cardiocom,s Commander Telehealth System provides an opportunity ... patient through an interactive "health check" that includes the ...
Cached Medicine Technology:Accuray Hires Chief Marketing Officer 2Accuray Hires Chief Marketing Officer 3Accuray Hires Chief Marketing Officer 4Cardiocom® Receives the 2010 TMCnet Smart Health Excellence Award for its Telehealth System 2Cardiocom® Receives the 2010 TMCnet Smart Health Excellence Award for its Telehealth System 3
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: